Intensity Therapeutics Competitors and Similar CompaniesClear all
Bexion Pharmaceuticals's competitors and similar companies include Acrivon and Numab.
 Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments. |  Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Covington, US HQ | Locations Watertown, US HQ Lund, SE | Locations Wädenswil, CH HQ |
Employees | Employees 274% increase | Employees 415% increase | Employees 681% decrease |
Funding | |||
Latest funding round | Latest funding round $ 16.6m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 110m (about 5 years ago) |
Total funding raised | Total funding raised $ 16.6m | Total funding raised N/A | Total funding raised $ 132.3m |
For sources of this data, please see the company profile
View Company Profiles
Acrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company